Wege, A. K., Chittka, D., Buchholz, S., Klinkhammer-Schalke, M., Diermeier-Daucher, S., Zeman, F., . . . Brockhoff, G. (2018). HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women. Breast Cancer Res.
Chicago Stili AlıntıWege, Anja Kathrin, Dominik Chittka, Stefan Buchholz, Monika Klinkhammer-Schalke, Simone Diermeier-Daucher, Florian Zeman, Olaf Ortmann, ve Gero Brockhoff. "HER4 Expression in Estrogen Receptor-positive Breast Cancer Is Associated With Decreased Sensitivity to Tamoxifen Treatment and Reduced Overall Survival of Postmenopausal Women." Breast Cancer Res 2018.
MLA AlıntıWege, Anja Kathrin, et al. "HER4 Expression in Estrogen Receptor-positive Breast Cancer Is Associated With Decreased Sensitivity to Tamoxifen Treatment and Reduced Overall Survival of Postmenopausal Women." Breast Cancer Res 2018.